Global Erythropoietin (EPO) Treatment Market Growth 2024-2030

Global Erythropoietin (EPO) Treatment Market Growth 2024-2030

Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused from end stage renal disease (ESRD) disease treatments and dialysis procedures. Followed by ESRD anemic condition, EPO drugs have gained approvals for chemotherapy-induced anemia. After post-abbreviated new drug application (ANDA) approvals and high success rate of EPO applications for chemotherapy-induced anemia, original biopharmaceutical companies turned their attention to another form of induced anemia, namely ART-induced anemia (among HIV patients).

The global Erythropoietin (EPO) Treatment market size is projected to grow from US$ 10530 million in 2024 to US$ 14860 million in 2030; it is expected to grow at a CAGR of 5.9% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Erythropoietin (EPO) Treatment Industry Forecast” looks at past sales and reviews total world Erythropoietin (EPO) Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Erythropoietin (EPO) Treatment sales for 2024 through 2030. With Erythropoietin (EPO) Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erythropoietin (EPO) Treatment industry.

This Insight Report provides a comprehensive analysis of the global Erythropoietin (EPO) Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erythropoietin (EPO) Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Erythropoietin (EPO) Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erythropoietin (EPO) Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erythropoietin (EPO) Treatment.

Rise in prevalence of anemic conditions induced from end stage renal disease treatment, chemotherapy, and antiretroviral treatment (ART) is the primary factor that propels growth of the erythropoietin market. Hence, rise in number of treatment cycles for chemotherapy and increase in incidences of end stage renal diseases (dialysis) has increased demand for EPO. Side effects associated with EPO including arterial hypertension, iron deficiency, and influenza-like syndrome and longer duration of EPO treatment (4-6 weeks) restrain growth of the erythropoietin drugs market. In addition, rise in trends of commercialization for erythropoietin biosimilars, readily available reimbursements, favorable government regulations, and increase in level of awareness regarding benefits of EPO therapeutics boost growth of the erythropoietin drugs market.

This report presents a comprehensive overview, market shares, and growth opportunities of Erythropoietin (EPO) Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Compression Moulding
Ram Extrusion
Gel Spinning
Others

Segmentation by Application:
Human Body Bulletproof
Automotive Bulletproof

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DSM
Honeywell
Xingi Technology
Hunan Zhongtai
Jonnyma New Material
Qianxi Longxian Special Fiber
ChangQingTeng High Performance Fiber Material
Shanghai Synertex Material Technology Co., Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Erythropoietin (EPO) Treatment market?

What factors are driving Erythropoietin (EPO) Treatment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Erythropoietin (EPO) Treatment market opportunities vary by end market size?

How does Erythropoietin (EPO) Treatment break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.